Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer's continuum

Neuroimage Clin. 2020:27:102282. doi: 10.1016/j.nicl.2020.102282. Epub 2020 May 26.

Abstract

Background: The recently-proposed National Institute on Aging and Alzheimer's Association research framework organizes Alzheimer's disease (AD) biomarkers based on amyloid/tau/neurodegeneration (AT(N)). This study investigated the mediating effect of structural change in brain MRI on changes in cognitive function according to initial AT(N) profiles.

Methods: We included 576 subjects (cognitively unimpaired (N = 136), mild cognitive impairment (N = 294), dementia (N = 146)) from the Alzheimer's disease Neuroimaging Initiative study. The parallel-process latent growth curve model was applied to test the mediational effect of cortical thickness growth trajectory between the initial AT(N) profiles and cognitive growth trajectory.

Results: In Alzheimer's continuum, only the A + T + (N)+ profile showed a mediational effect of the cortical thickness growth trajectory. A + T - (N)- was not sufficient to induce direct or indirect effects on cognitive dysfunction, and A + T + (N)- showed a significant direct path from an altered cortical thickness to cognitive decline.

Conclusion: The sequential effect between changes in brain MRI and cognition varied by baseline AT(N) profile, suggesting the dynamic changes in the relationships among biomarkers in the current cascade model.

Keywords: Alzheimer’s disease; Beta amyloid; Brain MRI; CSF biomarkers; Mild cognitive impairment; Parallel process latent growth curve model; Structural equation modeling; Tau.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / physiopathology*
  • Amyloid beta-Peptides / metabolism
  • Biomarkers / analysis
  • Brain / pathology
  • Brain / physiopathology*
  • Cognition / physiology*
  • Cognitive Dysfunction / physiopathology*
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Neuroimaging / methods

Substances

  • Amyloid beta-Peptides
  • Biomarkers